Squarepoint Portfolio holdings
AUM
$45.5B
1-Year Return
6.73%
This Quarter Return
+6.02%
1 Year Return
+6.73%
3 Year Return
+22.51%
5 Year Return
+41.07%
10 Year Return
+76.91%
AUM
$24.5B
AUM Growth
+$3.87B
(+19%)
Cap. Flow
+$1.27B
Cap. Flow
% of AUM
5.17%
Top 10 Holdings %
Top 10 Hldgs %
16.25%
Holding
3,120
New
601
Increased
921
Reduced
922
Closed
563
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$814M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$363M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$263M |
| 4 |
Apple
AAPL
|
+$211M |
| 5 |
Booking.com
BKNG
|
+$144M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
+$180M |
| 2 |
Intuit
INTU
|
+$179M |
| 3 |
Goldman Sachs
GS
|
+$161M |
| 4 |
Royal Caribbean
RCL
|
+$160M |
| 5 |
Bank of America
BAC
|
+$147M |
Sector Composition
| 1 | Technology | 20.16% |
| 2 | Consumer Discretionary | 17.05% |
| 3 | Healthcare | 10.48% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
MeiraGTx Holdings
MGTX
$617M
| $273K | ﹤0.01% |
38,854
+14,506
| +60% | +$102K |
|
2002
Superior Group of Companies
SGC
$196M
| $273K | ﹤0.01% |
20,201
-4,022
| -17% | -$54.3K |
|
|
TWKS
2003
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $273K | ﹤0.01% |
+56,660
| New | +$273K |
|
|
SUP
2004
DELISTED
Superior Industries International
SUP
| $272K | ﹤0.01% |
85,006
+30
| +0% | +$96 |
|
2005
Arvinas
ARVN
$573M
| $272K | ﹤0.01% |
6,602
-42,436
| -87% | -$1.75M |
|
2006
Gerdau
GGB
$6.21B
| $271K | ﹤0.01% |
+67,052
| New | +$271K |
|
2007
Oramed Pharmaceuticals
ORMP
$99.6M
| $271K | ﹤0.01% |
117,276
+64,432
| +122% | +$149K |
|
2008
Bath & Body Works
BBWI
$5.75B
| $266K | ﹤0.01% |
6,161
-53
| -0.9% | -$2.29K |
|
2009
Nuvation Bio
NUVB
$1.15B
| $263K | ﹤0.01% |
174,277
-29,829
| -15% | -$45K |
|
2010
Etsy
ETSY
$5.91B
| $263K | ﹤0.01% |
3,245
-291,688
| -99% | -$23.6M |
|
2011
Esperion Therapeutics
ESPR
$563M
| $262K | ﹤0.01% |
87,712
+59,743
| +214% | +$179K |
|
2012
Sinclair Inc
SBGI
$971M
| $262K | ﹤0.01% |
20,122
-100,038
| -83% | -$1.3M |
|
2013
C4 Therapeutics
CCCC
$194M
| $260K | ﹤0.01% |
+46,025
| New | +$260K |
|
2014
Knowles
KN
$1.91B
| $260K | ﹤0.01% |
14,494
-94,745
| -87% | -$1.7M |
|
2015
Northfield Bancorp
NFBK
$501M
| $258K | ﹤0.01% |
20,545
-13,375
| -39% | -$168K |
|
2016
REV Group
REVG
$3.12B
| $258K | ﹤0.01% |
+14,220
| New | +$258K |
|
2017
Webster Financial
WBS
$10.3B
| $258K | ﹤0.01% |
5,077
-70,278
| -93% | -$3.57M |
|
2018
Aldeyra Therapeutics
ALDX
$334M
| $256K | ﹤0.01% |
+72,964
| New | +$256K |
|
2019
CEVA Inc
CEVA
$570M
| $256K | ﹤0.01% |
11,268
-581
| -5% | -$13.2K |
|
2020
Barrett Business Services
BBSI
$1.22B
| $256K | ﹤0.01% |
+8,836
| New | +$256K |
|
2021
Universal Corp
UVV
$1.4B
| $254K | ﹤0.01% |
+3,777
| New | +$254K |
|
2022
ProQR Therapeutics
PRQR
$231M
| $254K | ﹤0.01% |
128,174
-4,204
| -3% | -$8.32K |
|
2023
Liquidia Corp
LQDA
$2.32B
| $253K | ﹤0.01% |
+21,071
| New | +$253K |
|
2024
Community Health Systems
CYH
$420M
| $253K | ﹤0.01% |
80,907
-85,767
| -51% | -$268K |
|
2025
News Corp Class A
NWSA
$16.6B
| $253K | ﹤0.01% |
10,313
-28
| -0.3% | -$687 |
|